HDBuzz reported live updates on Bluesky from the 2025 HD Therapeutics Conference. Read on for coverage of Day 3. #CHDI2025 ...

New research suggests that cognitive engagement - keeping your brain busy with activities like reading, puzzles, or learning ...

Up first is Amy-Lee Breadlau from PTC Therapeutics with an update on votoplam, formerly PTC-518. Votoplam is a HTT-lowering drug that’s taken as a pill. The idea is that by lowering the ...

In plain language. Written by scientists. For the global HD community.

Michael is a consultant neurologist in the department of neurology at the University of Ulm in Germany, and scientific projects manager for the European Huntington’s disease network. Michael trained ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...

Emma is a PhD student at UCL Institute of Neurology, where she works in Professor Sarah Tabrizi’s team. Her research explores the role of DNA repair in Huntington’s disease, which she hopes will ...

Lucy is a Research Assistant at the UCL Institute of Neurology, working in Professor Sarah Tabrizi’s team. Her research explores the role of transcription (converting DNA to RNA) of the huntingtin ...